Soumendu Bhattacharya,Chakravarthy Nachu Narasimhan,Manoj K. Sharma,Xiaoyu Yang,Arnab De,Rubi Burlage,Jason K. Cheung
申请号：
US16609671
公开号：
US20200262922A1
申请日:
2018.05.01
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to stable formulations comprising antibodies or antigen binding fragments thereof that bind to cytotoxic T lymphocyte associated antigen 4 (CTLA4), optionally further containing an anti-human programmed death receptor 1 (PD-1) antibody or antigen binding fragment thereof. Also provided are methods of treating various cancers and chronic infections with the formulations of the invention.
